{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T17:02:33Z","timestamp":1789405353069,"version":"build-2803163510"},"reference-count":16,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004881","name":"Instituto Mexicano del Seguro Social","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004881","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.arcmed.2026.103427","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T22:29:43Z","timestamp":1777328983000},"page":"103427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Role of Tumor Volume and Prolactin Ratios in Differentiating Prolactinomas and Predicting Response to Cabergoline"],"prefix":"10.1016","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9216-0383","authenticated-orcid":false,"given":"Manuel Ram\u00f3n","family":"Garc\u00eda-S\u00e1enz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas Iv\u00e1n","family":"Castro-Murillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mois\u00e9s","family":"Mercado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Francisco","family":"Avelar-Garnica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Sosa-Eroza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7590-7262","authenticated-orcid":false,"given":"Etual","family":"Espinosa-C\u00e1rdenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2026.103427_bib0001","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline","volume":"96","author":"Melmed","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2026.103427_bib0002","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1210\/clinem\/dgad174","article-title":"Approach to the Patient With Prolactinoma","volume":"108","author":"Auriemma","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2026.103427_bib0003","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1530\/EJE-13-0503","article-title":"Giant prolactinomas in women","volume":"170","author":"Delgrange","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arcmed.2026.103427_bib0004","doi-asserted-by":"crossref","first-page":"R213","DOI":"10.1530\/EJE-14-0013","article-title":"Therapy of endocrine disease: the challenges in managing giant prolactinomas","volume":"170","author":"Maiter","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arcmed.2026.103427_bib0005","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1023\/A:1022375429083","article-title":"Medical management of prolactin-secreting pituitary adenomas","volume":"5","author":"Molitch","year":"2002","journal-title":"Pituitary"},{"key":"10.1016\/j.arcmed.2026.103427_bib0006","doi-asserted-by":"crossref","first-page":"e488","DOI":"10.1016\/j.wneu.2021.12.074","article-title":"Serum Prolactin Level to Tumor Size Ratio as a Potential Parameter for Preoperative Differentiation of Prolactinomas from Hyperprolactinemia-Causing Non-functional Pituitary Adenomas","volume":"159","author":"Kim","year":"2022","journal-title":"World Neurosurg"},{"key":"10.1016\/j.arcmed.2026.103427_bib0007","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.eprac.2022.03.013","article-title":"The Prolactin per Unit Tumor Volume Ratio Accurately Distinguishes Prolactinomas From Secondary Hyperprolactinemia due to Stalk Effect","volume":"28","author":"Faje","year":"2022","journal-title":"Endocr Pract"},{"key":"10.1016\/j.arcmed.2026.103427_bib0008","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s12020-021-02744-8","article-title":"Tumor volume improves preoperative differentiation of prolactinomas and nonfunctioning pituitary adenomas","volume":"74","author":"Wright","year":"2021","journal-title":"Endocrine"},{"key":"10.1016\/j.arcmed.2026.103427_bib0009","first-page":"2010","article-title":"Role of prolactin\/adenoma maximum diameter and prolactin\/adenoma volume in the differential diagnosis of prolactinomas and other types of pituitary adenomas","volume":"15","author":"Huang","year":"2018","journal-title":"Oncol Lett"},{"key":"10.1016\/j.arcmed.2026.103427_bib0010","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3171\/2019.3.JNS19121","article-title":"Prolactinomas and nonfunctioning adenomas: preoperative diagnosis of tumor type using serum prolactin and tumor size","volume":"133","author":"Burke","year":"2020","journal-title":"J Neurosurg"},{"key":"10.1016\/j.arcmed.2026.103427_bib0011","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1530\/EJE-12-0236","article-title":"Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patients","volume":"167","author":"Vroonen","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arcmed.2026.103427_bib0012","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/s41574-023-00886-5","article-title":"Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement","volume":"19","author":"Petersenn","year":"2023","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.arcmed.2026.103427_bib0013","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.3171\/2022.8.JNS221890","article-title":"Correlation between tumor volume and serum prolactin and its effect on surgical outcomes in a cohort of 219 prolactinoma patients","volume":"138","author":"Osorio","year":"2023","journal-title":"J Neurosurg"},{"key":"10.1016\/j.arcmed.2026.103427_bib0014","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3803\/EnM.2014.29.3.280","article-title":"Early prediction of long-term response to cabergoline in patients with macroprolactinomas","volume":"29","author":"Lee","year":"2014","journal-title":"Endocrinol Metab (Seoul)"},{"key":"10.1016\/j.arcmed.2026.103427_bib0015","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s11102-025-01512-5","article-title":"Good response rates and predictors during the first year of cabergoline treatment in large invasive prolactinomas","volume":"28","author":"Bostan","year":"2025","journal-title":"Pituitary"},{"key":"10.1016\/j.arcmed.2026.103427_bib0016","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1210\/clinem\/dgab901","article-title":"Pituitary MRI Standard and Advanced Sequences: Role in the Diagnosis and Characterization of Pituitary Adenomas","volume":"107","author":"Gadelha","year":"2022","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440926000500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440926000500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T16:03:34Z","timestamp":1789401814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440926000500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0188440926000500"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2026.103427","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Tumor Volume and Prolactin Ratios in Differentiating Prolactinomas and Predicting Response to Cabergoline","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2026.103427","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103427"}}